Connor, Clark & Lunn Investment Management (CC&L)
NVS icon

Connor, Clark & Lunn Investment Management (CC&L)’s Novartis NVS Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$3.43M Sell
28,364
-64,632
-69% -$7.82M 0.01% 691
2025
Q1
$10.4M Buy
92,996
+84,563
+1,003% +$9.43M 0.05% 317
2024
Q4
$821K Sell
8,433
-182,884
-96% -$17.8M ﹤0.01% 1003
2024
Q3
$22M Buy
191,317
+113,260
+145% +$13M 0.11% 156
2024
Q2
$8.31M Buy
78,057
+67,095
+612% +$7.14M 0.03% 308
2024
Q1
$1.06M Sell
10,962
-66,251
-86% -$6.41M ﹤0.01% 868
2023
Q4
$7.8M Sell
77,213
-227,937
-75% -$23M 0.04% 322
2023
Q3
$31.1M Sell
305,150
-167,264
-35% -$17M 0.16% 117
2023
Q2
$47.7M Buy
472,414
+169,256
+56% +$17.1M 0.24% 82
2023
Q1
$27.9M Sell
303,158
-316,774
-51% -$29.1M 0.15% 118
2022
Q4
$56.2M Buy
619,932
+556,154
+872% +$50.5M 0.32% 58
2022
Q3
$4.85M Buy
63,778
+15,339
+32% +$1.17M 0.03% 327
2022
Q2
$4.1M Buy
+48,439
New +$4.1M 0.02% 350
2022
Q1
Sell
-45,565
Closed -$3.99M 1157
2021
Q4
$3.99M Buy
+45,565
New +$3.99M 0.02% 373
2020
Q3
Sell
-2,693
Closed -$235K 1063
2020
Q2
$235K Buy
2,693
+193
+8% +$16.8K ﹤0.01% 878
2020
Q1
$206K Sell
2,500
-124,575
-98% -$10.3M ﹤0.01% 866
2019
Q4
$12M Sell
127,075
-26,425
-17% -$2.5M 0.08% 166
2019
Q3
$13.3M Buy
153,500
+130,650
+572% +$11.4M 0.09% 149
2019
Q2
$2.09M Sell
22,850
-84,350
-79% -$7.7M 0.01% 426
2019
Q1
$10.3M Sell
107,200
-353,126
-77% -$33.9M 0.07% 186
2018
Q4
$39.5M Buy
460,326
+305,289
+197% +$26.2M 0.27% 70
2018
Q3
$13.4M Buy
+155,037
New +$13.4M 0.08% 180
2018
Q1
Sell
-58,900
Closed -$4.95M 778
2017
Q4
$4.95M Sell
58,900
-72,475
-55% -$6.08M 0.03% 291
2017
Q3
$11.3M Buy
+131,375
New +$11.3M 0.07% 190
2017
Q2
Sell
-6,900
Closed -$512K 904
2017
Q1
$512K Buy
+6,900
New +$512K ﹤0.01% 625
2013
Q4
Sell
-11,467
Closed -$904K 747
2013
Q3
$904K Buy
+11,467
New +$904K 0.01% 277